Luminex Corporation  

(Public, NASDAQ:LMNX)   Watch this stock  
Find more results for LMNX
+0.32 (2.06%)
May 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.49 - 15.97
52 week 15.05 - 21.69
Open 15.57
Vol / Avg. 171,929.00/223,263.00
Mkt cap 683.26M
P/E 17.11
Div/yield     -
EPS 0.93
Shares 42.91M
Beta 0.40
Inst. own 74%
May 14, 2015
Luminex Corp Annual Shareholders Meeting - 11:00AM EDT - Add to calendar
May 4, 2015
Q1 2015 Luminex Corp Earnings Call - 4:30PM EDT - Add to calendar
May 4, 2015
Q1 2015 Luminex Corp Earnings Release - 4:00PM EDT - Add to calendar
Mar 2, 2015
Luminex Corp at Cowen Health Care Conference
Feb 12, 2015
Luminex Corp at Leerink Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 39.24% 17.20%
Operating margin 17.53% 12.40%
EBITD margin - 19.48%
Return on average assets 26.59% 11.77%
Return on average equity 29.75% 13.24%
Employees 741 -
CDP Score - -


AUSTIN, TX 78727-6101
United States - Map
+1-512-2198020 (Phone)
+1-512-2195195 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Luminex Corporation, is a technologies and applications company. The Company develops, manufactures and sell biological testing technologies and products with applications in the life sciences and diagnostics industries. The Company provides the industries with bioassays tests, which perform diagnostic tests and conduct life science research. The Company is organized into two reportable segments: Technology and Strategic Partnerships (TSP) segment, and the Assays and Related products (ARP) segment. Technology and Strategic Partnerships segment, offers Instruments, Consumables, and Software. The TSP Instruments include compact analyzers, general laboratory instruments and multiplexing analyzer. The TSP Consumables include types of microspheres. The TSP Software assists in laboratory workflow. Assays and Related products segment, offers Assay Product Families which comprises of chemical and biological reagents use bead technology to perform diagnostic and research assays on samples.

Officers and directors

G. Walter Loewenbaum II Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Nachum Shamir President, Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Harriss T. Currie Chief Financial Officer, Senior Vice President - Finance, Treasurer
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Russell W. Bradley Senior Vice President, chief marketing and sales officer
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jeremy K Bridge-Cook Senior Vice President - Research and Development
Age: 46
Bio & Compensation  - Reuters
Nancy M. Fairchild Senior Vice President- Human resources
Age: 61
Bio & Compensation  - Reuters
Robert J. Cresci Independent Director
Age: 71
Bio & Compensation  - Reuters
Thomas W. Erickson Independent Director
Age: 64
Bio & Compensation  - Reuters
Fred C. Goad Independent Director
Age: 74
Bio & Compensation  - Reuters
Jay B. Johnston Independent Director
Age: 72
Bio & Compensation  - Reuters